Tobacco Use DisorderSmoking CessationSubstance-Related DisordersOpioid-Related DisordersAlcoholismBupropionTobacco Use Cessation ProductsTobacco Use CessationBuprenorphineDiagnosis, Dual (Psychiatry)Narcotic AntagonistsSmokingCocaine-Related DisordersSubstance PTreatment OutcomePsychomotor AgitationMarijuana AbuseBehavior, AddictiveDiagnostic and Statistical Manual of Mental DisordersAntisocial Personality DisorderMood DisordersGenes, OverlappingHeroin DependenceAgmatineMental DisordersGamblingStreet DrugsComorbidityPsychiatric Status Rating ScalesAmphetamine-Related DisordersConduct DisorderInterview, PsychologicalPsychotherapy, GroupImpulsive BehaviorPersonalityAfrican AmericansEuropean Continental Ancestry GroupIndians, North AmericanInheritance PatternsGenetic Predisposition to DiseasePersonality DisordersUnited StatesBipolar DisorderAnxiety DisordersPolymorphism, Single NucleotideStress Disorders, Post-TraumaticHaplotypesDepressive Disorder, MajorGene-Environment InteractionRisk FactorsGenome-Wide Association StudyCase-Control StudiesPrevalenceAge of OnsetLinkage DisequilibriumGene FrequencyNeuropsychological TestsGenotypeGenetic LinkageLogistic ModelsAnalysis of VarianceSubstance Abuse Treatment CentersLongitudinal StudiesSex FactorsHealth SurveysReceptors, Neurokinin-1QuestionnairesMorphine DependenceAge FactorsCross-Sectional StudiesGenome, HumanSubstance Withdrawal SyndromePolymorphism, GeneticKineticsThiobarbituric Acid Reactive SubstancesHumic SubstancesHazardous SubstancesHydrogen-Ion ConcentrationTemperatureTime FactorsTachykininsSubstance Abuse DetectionNeurokinin-1 Receptor AntagonistsMembrane PotentialsAlcohol DrinkingNeurokinin ACalciumDose-Response Relationship, Drug